Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asri Karya Lestari Tbk. (ASLI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Asri Karya Lestari Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Asri Karya Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp210 (market cap 1.22T, 25.66M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Asri Karya Lestari Tbk. is far larger — about 7.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Asri Karya Lestari Tbk. is more actively traded (25.66M versus 62.5K). Which is the better fit depends on your goals.

ASLIOBAT
Market Cap
1.22T164.65B
Volume
25.66M62.5K
Lot
256.58K625
Turnover
5.39B15.03M
Average Price
210.23240.55
Value
5.39B15.03M
Indicative Equilibrium Price
210238
Indicative Equilibrium Volume
4.18K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASLI
View details
OBAT
View details

About Asri Karya Lestari Tbk.

PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009

Read more on ASLI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT